332 related articles for article (PubMed ID: 1911826)
1. Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
Allen TM; Hansen C
Biochim Biophys Acta; 1991 Sep; 1068(2):133-41. PubMed ID: 1911826
[TBL] [Abstract][Full Text] [Related]
2. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.
Allen TM; Hansen C; Martin F; Redemann C; Yau-Young A
Biochim Biophys Acta; 1991 Jul; 1066(1):29-36. PubMed ID: 2065067
[TBL] [Abstract][Full Text] [Related]
3. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
Allen TM; Mehra T; Hansen C; Chin YC
Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
[TBL] [Abstract][Full Text] [Related]
4. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues.
Allen TM; Hansen C; Rutledge J
Biochim Biophys Acta; 1989 May; 981(1):27-35. PubMed ID: 2719971
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes.
Mori A; Wu SP; Han I; Khokhar AR; Perez-Soler R; Huang L
Cancer Chemother Pharmacol; 1996; 37(5):435-44. PubMed ID: 8599866
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection.
Allen TM; Hansen CB; Guo LS
Biochim Biophys Acta; 1993 Jul; 1150(1):9-16. PubMed ID: 8334142
[TBL] [Abstract][Full Text] [Related]
7. Novel long-circulating liposomes containing peptide library-lipid conjugates: synthesis and in vivo behavior.
Riché EL; Erickson BW; Cho MJ
J Drug Target; 2004 Jul; 12(6):355-61. PubMed ID: 15545085
[TBL] [Abstract][Full Text] [Related]
8. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
Maruyama K; Kennel SJ; Huang L
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
[TBL] [Abstract][Full Text] [Related]
9. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
10. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
Krishna R; Webb MS; St Onge G; Mayer LD
J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.
Webb MS; Saxon D; Wong FM; Lim HJ; Wang Z; Bally MB; Choi LS; Cullis PR; Mayer LD
Biochim Biophys Acta; 1998 Jul; 1372(2):272-82. PubMed ID: 9675310
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution.
Xu Y; Meng H
Artif Cells Nanomed Biotechnol; 2016; 44(1):350-5. PubMed ID: 25162671
[TBL] [Abstract][Full Text] [Related]
13. Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size.
Allen TM; Austin GA; Chonn A; Lin L; Lee KC
Biochim Biophys Acta; 1991 Jan; 1061(1):56-64. PubMed ID: 1995057
[TBL] [Abstract][Full Text] [Related]
14. Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine.
Chen J; Yan GJ; Hu RR; Gu QW; Chen ML; Gu W; Chen ZP; Cai BC
Int J Nanomedicine; 2012; 7():3567-77. PubMed ID: 22904620
[TBL] [Abstract][Full Text] [Related]
15. Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight.
Vertut-Doï A; Ishiwata H; Miyajima K
Biochim Biophys Acta; 1996 Jan; 1278(1):19-28. PubMed ID: 8611602
[TBL] [Abstract][Full Text] [Related]
16. Large liposomes containing ganglioside GM1 accumulate effectively in spleen.
Liu D; Mori A; Huang L
Biochim Biophys Acta; 1991 Jul; 1066(2):159-65. PubMed ID: 1854781
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
[TBL] [Abstract][Full Text] [Related]
18. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
19. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
[TBL] [Abstract][Full Text] [Related]
20. Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes.
Dos Santos N; Mayer LD; Abraham SA; Gallagher RC; Cox KA; Tardi PG; Bally MB
Biochim Biophys Acta; 2002 Apr; 1561(2):188-201. PubMed ID: 11997119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
